21P Cross-resistance between platinum-based chemotherapy (PlCh) and PARP inhibitors (PARPi) in castration-resistant prostate cancer (CRPC)
ESMO Open（2023）
关键词
parp inhibitors,prostate cancer,chemotherapy,cross-resistance,platinum-based,castration-resistant
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要